$93.37
-1.42-1.50%
Last update: Dec 16, 10:28 AM
Comments
Loading...
Protagonist Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:PTGX | Benzinga
Protagonist Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 20
EPS Estimate
$-0.550
Quarterly Revenue Estimate
$26.27M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$209.22M
Analyze the earnings history of Protagonist Therapeutics using advanced sorting and filters.
Protagonist Therapeutics (PTGX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $-0.62 | $-0.62 | 0.00 % |
| Q2 | 2025-08-06 | $-0.55 | $-0.53 | -3.77 % |
| Q1 | 2025-05-06 | $-0.19 | $0.11 | -272.7 % |
| Q4 | 2025-02-21 | $1.98 | $1.03 | 92.2 % |
Protagonist Therapeutics (PTGX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $4.71M | $6.48M | -27.3 % |
| Q2 | 2025-08-06 | $5.55M | $9.15M | -39.4 % |
| Q1 | 2025-05-06 | $28.32M | $30.44M | -6.96 % |
| Q4 | 2025-02-21 | $170.64M | $53.52M | 218.8 % |
FAQ
When is Protagonist Therapeutics (NASDAQ:PTGX) reporting earnings?
Protagonist Therapeutics (PTGX) is scheduled to report earnings on February 20, 2026. The last reported earnings were for reported on November 6, 2025 for Q3.
What were the latest earnings per share (EPS) for Protagonist Therapeutics (NASDAQ:PTGX)?
The Actual EPS was $-0.62, which hit the estimate of $-0.62.
What were Protagonist Therapeutics’s (NASDAQ:PTGX) revenues?
The Actual Revenue was $4.7M, which missed the estimate of $6.5M.
Browse earnings estimates, EPS, and revenue on all stocks.
